Nevertheless, our work provides evidence that hepatic KLF9 might be a therapeutic target for the treatment of androgen excess‐induced PCOS (for example, by adeno‐associated virus system [52, 53]), revealing an unrecognized important role of the liver in the development of PCOS. This evidence concerns the gene KLF9 and polycystic ovary syndrome.